Perioperative Outcomes in Transcarotid Artery Revascularization Versus Carotid Endarterectomy or Stenting Nationwide

医学 颈动脉内膜切除术 围手术期 颈动脉支架置入术 颈动脉 内科学 血运重建 心脏病学 动脉内膜切除术 心肌梗塞 外科
作者
Ian Ramsay,Joshua D. Burks,Victor M. Lu,Michael Silva,Ahmed Abdelsalam,Robert M. Starke,Evan Luther
出处
期刊:Operative Neurosurgery [Lippincott Williams & Wilkins]
被引量:4
标识
DOI:10.1227/ons.0000000000000865
摘要

Transcarotid artery revascularization (TCAR) is a newer treatment for carotid stenosis where the carotid artery is accessed directly in the neck for stenting. It is less invasive than carotid endarterectomy (CEA) and has less embolic potential than carotid artery stenting (CAS), but population-level utilization of TCAR and outcomes are currently unknown. Our study compares outcomes of TCAR with those of CEA and CAS.The National Inpatient Database was used for years 2015 to 2019. A multivariate logistic regression model was used to compare CEA, CAS, and TCAR outcomes with age, sex, race, hospital teaching status, symptomatic carotid disease status, side of procedure, intraoperative monitoring, and the weighted Elixhauser comorbidity score as covariates.TCAR comprised 0.69% of these procedures in 2016, rising to 1.35% in 2019. The inpatient rates of death, stroke, and myocardial infarction for TCAR were 0.63% (95% confidence interval: 0.36%, 1.06%), 0.42% (0.21%, 0.80%), and 1.46% (1.04%, 2.05%), respectively. Compared with CEA, TCAR had statistically insignificant difference odds of death, odds ratio (95% CI) for stroke was 0.47 (0.25, 0.87), and for myocardial infarction, it was 0.66 (0.37, 0.94). Compared with CAS, for TCAR, the odds ratio for death was 0.41 (0.24, 0.71), and for stroke, it was 0.48 (0.26, 0.91).TCAR is underutilized relative to other revascularization techniques yet has favorable outcomes compared with CEA and CAS. TCAR may be preferred to CAS in patients not surgical candidates for CEA and has a less invasive possibility for those eligible for CEA.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CJW完成签到 ,获得积分10
刚刚
韧迹完成签到 ,获得积分0
刚刚
mmd完成签到 ,获得积分10
刚刚
七一安完成签到 ,获得积分10
1秒前
浪麻麻完成签到 ,获得积分10
5秒前
包容的剑完成签到 ,获得积分10
9秒前
等待的大炮完成签到,获得积分10
9秒前
注水萝卜完成签到 ,获得积分10
11秒前
Chem34完成签到,获得积分10
19秒前
21秒前
量子星尘发布了新的文献求助10
21秒前
hhh2018687完成签到,获得积分10
21秒前
21秒前
22秒前
22秒前
22秒前
22秒前
23秒前
23秒前
23秒前
23秒前
23秒前
23秒前
23秒前
嘒彼小星完成签到 ,获得积分10
23秒前
23秒前
24秒前
24秒前
24秒前
24秒前
25秒前
ri_290完成签到,获得积分10
25秒前
26秒前
nsc发布了新的文献求助30
28秒前
nsc发布了新的文献求助10
28秒前
nsc发布了新的文献求助10
28秒前
nsc发布了新的文献求助10
28秒前
nsc发布了新的文献求助10
28秒前
nsc发布了新的文献求助10
28秒前
nsc发布了新的文献求助10
28秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038039
求助须知:如何正确求助?哪些是违规求助? 3575756
关于积分的说明 11373782
捐赠科研通 3305574
什么是DOI,文献DOI怎么找? 1819239
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022